rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Fred S. Knechtel

Chief Financial Officer

Company insider

Files Form 4 as: Chief Financial Officer, Profusa; Chief Financial Officer, Interpace Biosciences; SVP, CFO & Treasurer, Remy International.

In numbers

Trades disclosed
30
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
3
Companies where not an officer
0
First trade
21 Feb 2013
Last trade
21 Aug 2026
Last filed
4 Sep 2026

Companies traded

Where they are an officer
PFSA ProfusaOfficer · Medical Devices · last 21 Aug 20260 buys · 0 sells
Interpace BiosciencesOfficer · Medical Devices · last 29 Jan 20200 buys · 0 sells
Remy InternationalOfficer · last 30 Oct 20140 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
21 Aug 2026filed 4 Sep 2026PFSA ProfusaMedical DevicesSEC FORM 4 Code J—54,323 at $0.00filing
21 Aug 2026filed 4 Sep 2026PFSA ProfusaMedical DevicesSEC FORM 4 Code J—301,991 at $0.00filing
21 Aug 2026filed 4 Sep 2026PFSA ProfusaMedical DevicesSEC FORM 4 Code J—54,323 at $0.00filing
21 Aug 2026filed 4 Sep 2026PFSA ProfusaMedical DevicesSEC FORM 4 Code J—301,991 at $0.00filing
12 Aug 2026filed 19 Aug 2026PFSA ProfusaMedical DevicesSEC FORM 4 Code C$1.3M301,991 at $4.28filing
12 Aug 2026filed 19 Aug 2026PFSA Profusaoption or derivative · Medical DevicesSEC FORM 4 Code C—filing
12 Aug 2026filed 19 Aug 2026PFSA Profusaoption or derivative · Medical DevicesSEC FORM 4 Code C—filing
12 Aug 2026filed 19 Aug 2026PFSA ProfusaMedical DevicesSEC FORM 4 Code C$1.3M301,991 at $4.28filing
4 May 2026filed 5 May 2026PFSA Profusaoption or derivative · Medical DevicesSEC FORM 4 Code P—filing
4 May 2026filed 5 May 2026PFSA Profusaoption or derivative · Medical DevicesSEC FORM 4 Code P—filing
26 Jan 2026filed 2 Feb 2026PFSA ProfusaMedical DevicesSEC FORM 4 Code J—818,961filing
26 Jan 2026filed 2 Feb 2026PFSA Profusaoption or derivative · Medical DevicesSEC FORM 4 Code J—516,863 at $0.00filing
26 Jan 2026filed 2 Feb 2026PFSA Profusaoption or derivative · Medical DevicesSEC FORM 4 Code J—516,863 at $0.00filing
26 Jan 2026filed 2 Feb 2026PFSA ProfusaMedical DevicesSEC FORM 4 Code J—818,961filing
29 Jan 2020filed 3 Feb 2020Interpace Biosciencesoption or derivative · Medical DevicesSEC FORM 4 Code A—60,000 at $0.00filing
30 Oct 2014filed 30 Oct 2014Remy InternationalSEC FORM 4 Code D—63,731 at $0.00filing
30 Oct 2014filed 30 Oct 2014Remy Internationaloption or derivativeSEC FORM 4 Code D—23,732 at $0.00filing
30 Oct 2014filed 30 Oct 2014Remy Internationaloption or derivativeSEC FORM 4 Code D—31,838 at $0.00filing
27 Feb 2014filed 3 Mar 2014Remy InternationalSEC FORM 4 Code F$92K4,097 at $22.41filing
27 Feb 2014filed 3 Mar 2014Remy InternationalSEC FORM 4 Code D—905 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Jack E. StoverChief Executive Officer · Chief Executive Officer at Profusa, filing Form 4 there in the last year
Vijay AggarwalDirector · Director at Interpace Biosciences, filing Form 4 there in the last year
Stephen J. SullivanDirector · Director at Interpace Biosciences, filing Form 4 there in the last year
Joseph D. KeeganDirector · Director at Interpace Biosciences, filing Form 4 there in the last year
Fortunato R. RoccaDirector · Director at Interpace Biosciences, filing Form 4 there in the last year